• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

Advertisement

Document › Details

Metabolon, Inc.. (11/28/11). "Press Release: Metabolon Announces Accreditation by College of American Pathologists". Research Triangle Park, N.C..

	Region	Research Triangle Park, NC
	Country	United States (USA)
	Organisation	Metabolon Inc.
	Product	laboratory services
	Product 2	clinical diagnostics
	Person	Ryals, John (Metabolon 200510 CEO)

Metabolon, Inc., a diagnostics and services company offering the industry's leading biochemical profiling technology, announced today that they have received laboratory accreditation from the College of American Pathologists (CAP).

The CAP Laboratory Accreditation Program is the premier globally-recognized program for laboratory accreditation and the only one of its kind that utilizes practicing laboratory professionals as inspectors. Designed to exceed government regulatory compliance standards, the program assists laboratories to achieve the highest levels of excellence to positively impact patient care. CAP accreditation is based on rigorous standards translated into specific clinically recognized laboratory procedures and methods.

Metabolon's CEO John Ryals said, "This accreditation means that Metabolon has met exceptionally rigorous standards in order to achieve the highest caliber of diagnostic testing quality. Our CAP accredited lab facility will offer tests developed using Metabolon's proprietary biochemical profiling technology. The first of these new tests will be Quantose IR for the evaluation of insulin resistance." Insulin resistance is a primary risk factor for the development of Type 2 diabetes and cardiovascular disease.


About Metabolon

Metabolon, Inc. has advanced the field of metabolomics by pioneering and patenting the industry's leading biochemical biomarker discovery and profiling platform. It has developed the technology to quickly identify and measure all of the biochemicals in a biological sample through its proprietary global processing method. Through the generation and interpretation of data, this method provides a precise understanding of disease etiology and drug action, and advances personalized medicine beyond what genomics and other approaches can promise. Metabolon's expertise is being embraced by a wide range of pharmaceutical, biotechnology, food and agricultural companies. Metabolytics, its biomarker discovery and analysis business, has completed over 320 client studies and processed over 30,000 samples for customers in 2010 alone. Building on its expertise in biochemistry understanding, Metabolon is also developing proprietary diagnostic tests to determine and track disease progression. For more information about Metabolon, please visit www.metabolon.com or contact Matt Zaske at mzaske@metabolon.com or 919-595-2200.

Media Contact:
LHA
Mackenzie Mills
mmills@lhai.com
212-838-3777

Record changed: 2011-12-04

More documents for Metabolon Inc.

• [1] Metabolon, Inc.. (10/19/11). "Press Release: Metabolomics Insight into Periodontal Disease Published in the Journal of Dental Research. Data Reveal Altered Host-bacteria Interactions Associated with Periodontitis". Research Triangle Park, N.C.....
• [2] Metabolon, Inc.. (8/29/11). "Press Release: Metabolon Secures $13 Million in Series D Financing. New Investors Include Keating Capital". Research Triangle Park, N.C.....
• [3] Metabolon, Inc.. (6/24/11). "Press Release: Metabolon Announces Resistance Biomarker Poster Presentations at American Diabetes Association Meeting". Research Triangle Park, NC....
• [4] Metabolon, Inc.. (6/17/11). "Press Release: USPTO Grants Two New Patents to Metabolon, Inc.". Research Triangle Park, NC....
• [5] Metabolon, Inc.. (6/9/11). "Press Release: Metabolomics Study Provides Insight into Ovary Metabolome and Cancer-associated Metabolic Changes Report Investigators from University of Louisville and Mebabolon". Research Triangle Park, NC....
• [6] Metabolon, Inc.. (6/8/11). "Press Release: Metabolomics Study Reveals 3-Indaxyl Sulfate as a Sensitive and Early Biomarker of Nephrotoxicity Report Investigators from Merck and Metabolon". Research Triangle Park, NC....
• [7] Metabolon, Inc.. (5/4/11). "Press Release: Metabolon Awarded Patent in Metabolomics Methods for Drug Discovery". Research Triangle Park, NC....
• [8] Metabolon, Inc.. (4/28/11). "Press Release: Metabolomics Insight into Underlying Desiccation Tolerance in Plants Published in the Plant Cell. Data Targeted at Improving Drought Tolerance in Crops". Research Triangle Park, NC....
• [9] Metabolon, Inc.. (12/20/10). "Press Release: Metabolon Identifies Adenosine-mediated Sickling in Sickle Cell Disease and Associated End Organ Damage". Research Triangle Park, NC....
• [10] Metabolon, Inc.. (11/30/10). "Press Release: Metabolomics Technology Applied to Diabetes Research". Research Triangle Park, NC....

To subscribe to our free, monthly [MSC] Newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

NEW: Visit our brand new forthcoming web portals Life-Sciences-Germany.com and Life-Sciences-Europe.com

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2012. Made in Germany.